TransMedics Group, Inc. (TMDX) News

TransMedics Group, Inc. (TMDX): $142.01

1.39 (-0.97%)

POWR Rating

Component Grades

Momentum

F

Stability

F

Sentiment

Quality

D

Filter TMDX News Items

TMDX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

TMDX News Highlights

  • TMDX's 30 day story count now stands at 3.
  • Over the past 14 days, the trend for TMDX's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • TOP, LUNG and DKNG are the most mentioned tickers in articles about TMDX.

Latest TMDX News From Around the Web

Below are the latest news stories about TRANSMEDICS GROUP INC that investors may wish to consider to help them evaluate TMDX as an investment opportunity.

Fund manager's top growth stock picks for 2024

As 2023 comes to a close, Clough Capital CEO and President Vince Lorusso discusses his top stock picks as we move into the new year. When discussing the funds he manages, Lorusso says, "There's really two different areas of investments. I kind of characterize them as stable growth companies, meaning they might be a little bit more defensive if we do have a little bit of a slowdown in the consumer." Lorusso's top picks for stable growth include Service Corporation International (SCI), Rollins, Inc. (ROL), and gold miners and utilities sectors. "In the other part of the portfolio, are these more dynamic growth companies that we think do have more beta potentially and are most exposed to some of the secular and also cyclical enthusiasm we're seeing around things like AI and EVs." Lorusso's...

Yahoo | December 26, 2023

TransMedics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will present at the upcoming 42nd Annual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 8, 2024, at 3:00 p.m. Pacific Standard Time / 6:00 p.m. Eastern Standard Time.

Yahoo | December 18, 2023

TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that on December 7, 2023, TransMedics granted non-qualified stock options to purchase an aggregate of 9,547 shares of its common stock and an aggregate of 6,175 restricted stock units to 11 employees, each as a material inducement for each employee's entry into employment with TransMedics. Th

Yahoo | December 12, 2023

Got $2,000? 3 Growth Stocks to Buy That Could Double Your Money

Here are three stocks to buy that could double your money. If Wall Street is right, Madrigal Pharmaceuticals (NASDAQ: MDGL) stock could go a long way toward doubling your money over the next 12 months. Madrigal could win U.S. Food and Drug Administration (FDA) approval for resmetirom in treating nonalcoholic steatohepatitis (NASH) by March 14, 2024.

Yahoo | November 30, 2023

Investing in These 3 Stocks Now Could Make You a Millionaire Retiree

Let me be clear upfront. To have a decent chance of retiring with $1 million or more, you're going to need cash to invest and plenty of time. Exactly how much cash and how much time is required will vary.

Yahoo | November 25, 2023

Prediction: 3 Stocks That Could Trounce the Market

Mastercard (NYSE: MA) is lagging behind the S&P 500 a little so far in 2023. Along with Visa, Mastercard enjoys a duopoly in the credit card payment processing market. The company has a well-known brand that consumers, banks, and merchants trust.

Yahoo | November 23, 2023

TransMedics to Present at the Piper Sandler 35th Annual Healthcare Conference

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will participate in a fireside chat at the upcoming Piper Sandler 35th Annual Healthcare Conference in New York. The fireside chat will take place on Tuesday, November 28, 2023, at 2:30 p.m. Eastern Time.

Yahoo | November 14, 2023

3 Revolutionary Stocks I'd Buy Right Now Without Hesitation

As is the case with other bold adjectives, revolutionary is sometimes used to describe things that really don't live up to the billing. Here are three revolutionary stocks I'd buy right now without hesitation (listed in alphabetical order). Sure, Intuitive Surgical (NASDAQ: ISRG) has been selling its da Vinci robotic surgical systems for over 20 years.

Yahoo | November 12, 2023

Here's What Key Metrics Tell Us About TransMedics (TMDX) Q3 Earnings

The headline numbers for TransMedics (TMDX) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Yahoo | November 10, 2023

2 Top Growth Stocks to Buy Right Now and Hold for the Long Term

Not only are these two stocks projected to grow sales by 36% and 112% this year, they're poised to start generating profits in 2024.

Yahoo | November 10, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!